ATE211918T1 - Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium - Google Patents

Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium

Info

Publication number
ATE211918T1
ATE211918T1 AT97944746T AT97944746T ATE211918T1 AT E211918 T1 ATE211918 T1 AT E211918T1 AT 97944746 T AT97944746 T AT 97944746T AT 97944746 T AT97944746 T AT 97944746T AT E211918 T1 ATE211918 T1 AT E211918T1
Authority
AT
Austria
Prior art keywords
extract
production
parthenium integrifolium
medicine
integrifolium
Prior art date
Application number
AT97944746T
Other languages
English (en)
Inventor
Morten Sloth Weidner
Original Assignee
Morten Sloth Weidner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morten Sloth Weidner filed Critical Morten Sloth Weidner
Application granted granted Critical
Publication of ATE211918T1 publication Critical patent/ATE211918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT97944746T 1996-10-21 1997-10-20 Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium ATE211918T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK115896 1996-10-21
US3139596P 1996-11-19 1996-11-19
PCT/DK1997/000457 WO1998017292A1 (en) 1996-10-21 1997-10-20 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium

Publications (1)

Publication Number Publication Date
ATE211918T1 true ATE211918T1 (de) 2002-02-15

Family

ID=26065310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97944746T ATE211918T1 (de) 1996-10-21 1997-10-20 Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium

Country Status (10)

Country Link
US (1) US6217877B1 (de)
EP (1) EP1007067B1 (de)
JP (1) JP4346685B2 (de)
AT (1) ATE211918T1 (de)
AU (1) AU711019B2 (de)
DE (1) DE69709691T2 (de)
DK (1) DK1007067T3 (de)
ES (1) ES2172006T3 (de)
PT (1) PT1007067E (de)
WO (1) WO1998017292A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277978B1 (en) 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
CA2363590A1 (en) * 1999-03-10 2000-09-14 G.D. Searle & Co. Method and composition for administering a cyclooxygenase-2 inhibitor
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
CO5261556A1 (es) 1999-12-08 2003-03-31 Pharmacia Corp Composiciones inhibidoras de ciclooxigenasa-2 que tiene rapido acceso de efecto terapeutico
AU2001285334A1 (en) 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
WO2002047706A2 (en) * 2000-12-15 2002-06-20 Pharmacia Corporation Selective cox-2 inhibition from plant extracts
AU2003237487A1 (en) * 2002-06-14 2003-12-31 Smith And Nephew, Inc. Device and methods for placing external fixation elements
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
TWI344959B (en) * 2003-04-02 2011-07-11 Nat Health Research Institutes Treatment of hepatitis c virus infection with sesquiterpene lactones
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
EP1829874B1 (de) * 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclische verbindung und deren verwendung
TW200719884A (en) * 2005-03-10 2007-06-01 3M Innovative Properties Co Methods of treating ear infections
WO2006099359A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of reducing microbial contamination
MX2007010908A (es) * 2005-03-10 2007-12-05 3M Innovative Properties Co Composiciones antimicrobianas que comprenden esteres de acidos hidroxicarboxilicos.
EP2030628B1 (de) * 2006-06-01 2012-08-15 Yun Cheng Peptid zur prophylaxe oder therapie von leberschäden sowie ein derivat davon und seine verwendung
CN104721602A (zh) * 2013-12-19 2015-06-24 汤丽娟 一种治疗腹型偏头痛的中药
CN113616747B (zh) * 2021-05-20 2023-03-24 天津中医药大学 一种感染性疾病康复用的中药组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
DE3638715A1 (de) * 1986-11-13 1988-05-26 Lohmann Rudolf Lomapharm Sesquiterpenverbindungen, verfahren zu ihrer isolierung und arzneimittel, enthaltend diese verbindungen
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
WO1993013787A1 (fr) * 1987-03-27 1993-07-22 Michio Fujimaki Agent d'immunopotentialisation

Also Published As

Publication number Publication date
EP1007067A1 (de) 2000-06-14
DK1007067T3 (da) 2002-05-06
JP4346685B2 (ja) 2009-10-21
EP1007067B1 (de) 2002-01-16
US6217877B1 (en) 2001-04-17
JP2001501919A (ja) 2001-02-13
PT1007067E (pt) 2002-07-31
DE69709691T2 (de) 2002-08-22
AU4615897A (en) 1998-05-15
DE69709691D1 (de) 2002-02-21
AU711019B2 (en) 1999-10-07
WO1998017292A1 (en) 1998-04-30
ES2172006T3 (es) 2002-09-16

Similar Documents

Publication Publication Date Title
DE69709691D1 (de) Pharmazeutische zusammenstellungen mit parthenium integrifolium oder mit einem extrakt oder einer komponente davon, verwendung dieses pflanzenmaterials zur herstellung von medizin und ein verfahren zur extraktherstellung von parthenium integrifolium
ATE350048T1 (de) Neue synergistische zusammensetzungen, die aromatische verbindungen und in alpinia galanga vorhandene terpenoide enthalten
NO972315L (no) Aerogelholdig komposittmateriale, fremgangsmåte for fremstilling derav samt anvendelse av materialet
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
ES2193130T3 (es) Procedimiento para incrementar la acumulacion de esteroles en plantas.
PL325635A1 (en) Application in a composition of at least one representative of labiatae family
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
DK0787112T3 (da) Aerogelholdig sammensætning, fremgangsmåde til dens fremstilling samt dens anvendelse
ES2152394T3 (es) Composicion para inhalacion que contiene granulos de lactosa.
AU3713784A (en) Compositions of plant extracts for treating capilliary fragility
ATE223213T1 (de) Konjugierte linoleinsäure zur erhaltung oder erhöhung des knochenmineraliengehaltes
ZA9210124B (en) Method for adhering to hard tissue.
ES2148813T3 (es) Procedimiento para la elaboracion de plantas que contienen proteinas.
FI972413A0 (fi) Kosmeettinen kaoliinipitoinen valmiste
ATE254924T1 (de) Stör-notokord zur verminderung der symptome / behandlung von arthritis
DE68928351D1 (de) Verfahren zur Herstellung von Polymerteilchen, Verfahren zur Herstellung von "Toner"-teilchen, und durch dieses Verfahren hergestellte Teilchen
ES506106A0 (es) Procedimiento para la preparacion de barnices termoendureci-bles, diluibles con agua
DE69624370D1 (de) Verfarhen zur herstellung von glycogen oder glycogenreichem hefeextrakt aus hefezellen und kosmetische zusammensetzungen, die diese enthalten
CA2075077A1 (en) Stevia extract-containing liquid internal medicine and method of preparing the same
IL93988A0 (en) Substituted 1,8-naphthyridines,their preparation and medicaments comprising them
DE19981493D2 (de) Verfahren zur Herstellung einer biologischen Substanz sowie derartige Substanz und deren Verwendung
ATE86492T1 (de) Anwendung von sterolinen und spiroketalinen zur herstellung von medikamenten zur behandlung von psoriasis.
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
NZ290050A (en) Treatment of anxiety with gabapentin
DE69319341D1 (de) Verfahren und zusammensetzungen zur behandlung von krankheiten verbunden mit mangelhaften immunfunktion

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007067

Country of ref document: EP

REN Ceased due to non-payment of the annual fee